US Stock MarketDetailed Quotes

APLT Applied Therapeutics

Watchlist
  • 8.270
  • -0.140-1.66%
Close Sep 27 16:00 ET
  • 8.350
  • +0.080+0.97%
Post 20:02 ET
949.78MMarket Cap-5783P/E (TTM)

Applied Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
144K
-98.22%190K
9.99M
-667K
0
0
10.66M
0
0
0
Operating revenue
--144K
-98.22%190K
--9.99M
---667K
--0
--0
--10.66M
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
19.84%20.58M
-1.09%21.28M
-10.15%74.53M
7.22%20.34M
-19.95%15.5M
-20.19%17.18M
-6.85%21.52M
-21.46%82.95M
-30.03%18.97M
-31.92%19.36M
Selling and administrative expenses
99.89%10.58M
62.39%9.07M
-24.50%20.62M
-26.77%5.04M
-24.52%4.71M
-13.58%5.29M
-30.83%5.58M
-36.55%27.32M
-39.60%6.88M
-42.40%6.24M
-General and administrative expense
99.89%10.58M
62.39%9.07M
-24.50%20.62M
-26.77%5.04M
-24.52%4.71M
-13.58%5.29M
-30.83%5.58M
-36.55%27.32M
-39.60%6.88M
-42.40%6.24M
Research and development costs
-15.81%10M
-23.33%12.22M
-3.11%53.91M
26.55%15.3M
-17.77%10.79M
-22.82%11.88M
6.02%15.94M
-11.09%55.63M
-23.10%12.09M
-25.46%13.12M
Operating profit
-19.00%-20.44M
-94.26%-21.09M
22.20%-64.54M
-10.73%-21.01M
19.95%-15.5M
20.19%-17.18M
53.00%-10.86M
21.46%-82.95M
30.03%-18.97M
31.92%-19.36M
Net non-operating interest income expense
53.92%628K
165.16%586K
100.29%1.37M
29.89%352K
72.69%392K
267.57%408K
190.79%221K
23.42%685K
15.81%271K
198.68%227K
Non-operating interest income
53.92%628K
165.16%586K
100.29%1.37M
29.89%352K
72.69%392K
267.57%408K
190.79%221K
--685K
--271K
198.68%227K
Other net income (expense)
277.30%22.71M
-12,786.20%-63.43M
-23,192.18%-56.6M
-498.48%-17.02M
-97,482.14%-27.27M
-188.04%-12.81M
620.83%500K
53.36%-243K
1,631.18%4.27M
143.75%28K
Gain on sale of security
277.63%22.74M
-13,619.19%-63.41M
-85,616.67%-56.57M
-498.64%-16.96M
-75,869.44%-27.28M
-193.87%-12.8M
--469K
---66K
--4.26M
--36K
Other non- operating income (expenses)
-580.00%-34K
-183.87%-26K
84.75%-27K
-458.82%-61K
225.00%10K
94.44%-5K
132.29%31K
66.03%-177K
106.09%17K
87.50%-8K
Income before tax
109.80%2.9M
-728.04%-83.94M
-45.15%-119.76M
-161.13%-37.68M
-121.82%-42.37M
-14.39%-29.58M
56.16%-10.14M
21.86%-82.51M
46.87%-14.43M
32.79%-19.1M
Income tax
Net income
109.80%2.9M
-728.04%-83.94M
-45.15%-119.76M
-161.13%-37.68M
-121.82%-42.37M
-14.39%-29.58M
56.16%-10.14M
21.86%-82.51M
46.87%-14.43M
32.79%-19.1M
Net income continuous Operations
109.80%2.9M
-728.04%-83.94M
-45.15%-119.76M
-161.13%-37.68M
-121.82%-42.37M
-14.39%-29.58M
56.16%-10.14M
21.86%-82.51M
46.87%-14.43M
32.79%-19.1M
Minority interest income
Net income attributable to the parent company
109.80%2.9M
-728.04%-83.94M
-45.15%-119.76M
-161.13%-37.68M
-121.82%-42.37M
-14.39%-29.58M
56.16%-10.14M
21.86%-82.51M
46.87%-14.43M
32.79%-19.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
109.80%2.9M
-728.04%-83.94M
-45.15%-119.76M
-161.13%-37.68M
-121.82%-42.37M
-14.39%-29.58M
56.16%-10.14M
21.86%-82.51M
46.87%-14.43M
32.79%-19.1M
Basic earnings per share
105.41%0.02
-272.22%-0.67
34.86%-1.42
-106.25%-0.33
-17.50%-0.47
61.46%-0.37
79.55%-0.18
47.09%-2.18
84.62%-0.16
63.30%-0.4
Diluted earnings per share
64.86%-0.13
-272.22%-0.67
34.86%-1.42
-106.25%-0.33
-17.50%-0.47
61.46%-0.37
79.55%-0.18
47.09%-2.18
84.62%-0.16
63.30%-0.4
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 144K-98.22%190K9.99M-667K0010.66M000
Operating revenue --144K-98.22%190K--9.99M---667K--0--0--10.66M--0--0--0
Cost of revenue
Gross profit
Operating expense 19.84%20.58M-1.09%21.28M-10.15%74.53M7.22%20.34M-19.95%15.5M-20.19%17.18M-6.85%21.52M-21.46%82.95M-30.03%18.97M-31.92%19.36M
Selling and administrative expenses 99.89%10.58M62.39%9.07M-24.50%20.62M-26.77%5.04M-24.52%4.71M-13.58%5.29M-30.83%5.58M-36.55%27.32M-39.60%6.88M-42.40%6.24M
-General and administrative expense 99.89%10.58M62.39%9.07M-24.50%20.62M-26.77%5.04M-24.52%4.71M-13.58%5.29M-30.83%5.58M-36.55%27.32M-39.60%6.88M-42.40%6.24M
Research and development costs -15.81%10M-23.33%12.22M-3.11%53.91M26.55%15.3M-17.77%10.79M-22.82%11.88M6.02%15.94M-11.09%55.63M-23.10%12.09M-25.46%13.12M
Operating profit -19.00%-20.44M-94.26%-21.09M22.20%-64.54M-10.73%-21.01M19.95%-15.5M20.19%-17.18M53.00%-10.86M21.46%-82.95M30.03%-18.97M31.92%-19.36M
Net non-operating interest income expense 53.92%628K165.16%586K100.29%1.37M29.89%352K72.69%392K267.57%408K190.79%221K23.42%685K15.81%271K198.68%227K
Non-operating interest income 53.92%628K165.16%586K100.29%1.37M29.89%352K72.69%392K267.57%408K190.79%221K--685K--271K198.68%227K
Other net income (expense) 277.30%22.71M-12,786.20%-63.43M-23,192.18%-56.6M-498.48%-17.02M-97,482.14%-27.27M-188.04%-12.81M620.83%500K53.36%-243K1,631.18%4.27M143.75%28K
Gain on sale of security 277.63%22.74M-13,619.19%-63.41M-85,616.67%-56.57M-498.64%-16.96M-75,869.44%-27.28M-193.87%-12.8M--469K---66K--4.26M--36K
Other non- operating income (expenses) -580.00%-34K-183.87%-26K84.75%-27K-458.82%-61K225.00%10K94.44%-5K132.29%31K66.03%-177K106.09%17K87.50%-8K
Income before tax 109.80%2.9M-728.04%-83.94M-45.15%-119.76M-161.13%-37.68M-121.82%-42.37M-14.39%-29.58M56.16%-10.14M21.86%-82.51M46.87%-14.43M32.79%-19.1M
Income tax
Net income 109.80%2.9M-728.04%-83.94M-45.15%-119.76M-161.13%-37.68M-121.82%-42.37M-14.39%-29.58M56.16%-10.14M21.86%-82.51M46.87%-14.43M32.79%-19.1M
Net income continuous Operations 109.80%2.9M-728.04%-83.94M-45.15%-119.76M-161.13%-37.68M-121.82%-42.37M-14.39%-29.58M56.16%-10.14M21.86%-82.51M46.87%-14.43M32.79%-19.1M
Minority interest income
Net income attributable to the parent company 109.80%2.9M-728.04%-83.94M-45.15%-119.76M-161.13%-37.68M-121.82%-42.37M-14.39%-29.58M56.16%-10.14M21.86%-82.51M46.87%-14.43M32.79%-19.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 109.80%2.9M-728.04%-83.94M-45.15%-119.76M-161.13%-37.68M-121.82%-42.37M-14.39%-29.58M56.16%-10.14M21.86%-82.51M46.87%-14.43M32.79%-19.1M
Basic earnings per share 105.41%0.02-272.22%-0.6734.86%-1.42-106.25%-0.33-17.50%-0.4761.46%-0.3779.55%-0.1847.09%-2.1884.62%-0.1663.30%-0.4
Diluted earnings per share 64.86%-0.13-272.22%-0.6734.86%-1.42-106.25%-0.33-17.50%-0.4761.46%-0.3779.55%-0.1847.09%-2.1884.62%-0.1663.30%-0.4
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data